| Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 |
|---|---|---|---|---|---|
Gross Sales | 3,085.51 | 3,040.21 | 3,611 | 3,638.56 | 0 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,085.51 | 3,040.21 | 3,611 | 3,638.56 | 0 |
Other Operating Income | 40.84 | 21.15 | 16.71 | 15.05 | 0 |
Other Income | 29.46 | 25.87 | 24.37 | 22.3 | 0 |
Total Income | 3,155.81 | 3,087.23 | 3,652.08 | 3,675.91 | 0 |
Total Expenditure | 2,754.01 | 2,731.48 | 3,182.67 | 2,964.19 | 0 |
PBIDT | 401.8 | 355.75 | 469.41 | 711.72 | 0 |
Interest | 41.73 | 39.04 | 15.88 | 24.82 | 0 |
PBDT | 360.07 | 316.71 | 453.53 | 686.9 | 0 |
Depreciation | 118.24 | 100.45 | 92.34 | 92.47 | 0 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 59.99 | 41.29 | 58.73 | 108.36 | 0 |
Deferred Tax | 4.72 | 21.33 | 47.27 | 77.95 | 0 |
Reported Profit After Tax | 177.12 | 153.64 | 255.19 | 408.12 | 0 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 177.12 | 153.64 | 255.19 | 408.12 | 0 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 177.12 | 153.64 | 255.19 | 408.12 | 0 |
EPS (Unit Curr.) | 11.2 | 9.71 | 16.05 | 25.67 | 0 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 250 | 250 | 250 | 250 | 0 |
Equity | 15.81 | 15.8 | 15.9 | 15.9 | 0.05 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 13.02 | 11.7 | 12.99 | 19.56 | 0 |
PBDTM(%) | 11.66 | 10.41 | 12.55 | 18.87 | 0 |
PATM(%) | 5.74 | 5.05 | 7.06 | 11.21 | 0 |
The board approved this acquisition on December 30, 2024. The equity bought of 6.67% was from Hero Fincorp Ltd and Sunil Kant Munjal.
In Q2 FY25, the company's total EBITDA increased by 7% year on year to ₹135 Crore, up from ₹126 Crore the previous year.
The company stated that its production facility in Bharuch successfully completed its USFDA inspection with zero 483 findings.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
